WSJ - US Business

FDA Blesses Blindness Treatment That Could Cost $1 Million

The Food and Drug Administration approved for sale the first therapy in the U.S. that delivers a functional gene to replace a faulty, disease-causing one—a treatment that could carry a price in excess of $ 1 million, its maker has said.

The injected gene therapy from Spark Therapeutics Inc. is designed to improve sight in people with a rare form of vision loss caused by an inherited genetic mutation. The condition, retinal dystrophy, often manifests itself in young children and affects up to 3,000 Americans, Spark said. US Business

Click to comment
Loading Facebook Comments ...

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top